Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

CANTON, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced the favorable outcome of the interim analysis of its second Phase 3 randomized control trial of ReNu, a cryopreserved amniotic suspension allograft (ASA), for the management of symptoms associated with knee osteoarthritis (OA).

Follow this link:
Organogenesis Reports Positive Interim Analysis of Second Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan

HUNTSVILLE, AL, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its lead IND candidate SER-252 for advanced Parkinson's disease, enabled by its proprietary POZ Platform™ drug optimization technology, announced that it has made grants of options to purchase an aggregate of 60,500 shares of Serina’s common stock to three new non-executive employees on November 6, 2024 (each, an “Option Grant”). Each Option Grant has an exercise price equal to the closing price of Serina’s common stock on November 6, 2024. The Option Grants were offered as material inducement to the employees’ employment. The Option Grants were approved by the Compensation Committee of Serina’s Board of Directors on November 6, 2024 pursuant to Serina’s 2024 Inducement Equity Plan to align their interests with Serina’s stockholders and to promote the success of Serina’s business. The Option Grants were made in reliance on the employment inducement exemption under the NYSE American’s Company Guide Section 711(a) which requires public disclosure of inducement awards. Serina is issuing this press release pursuant to Section 711(a) of NYSE American’s Company Guide. The Option Grants shall vest and become exercisable with respect to one-third of the aggregate number of shares subject to each Option Grant on the first anniversary of the grant date, and the remaining two-thirds of the aggregate number of shares subject to each Option Grant shall vest in a series of 24 substantially equal monthly installments thereafter, such that the Option Grant will be vested as of the third anniversary of the grant date, subject to continued employment with Serina.

Continue reading here:
Serina Therapeutics Makes Grants to New Employees Under Inducement Plan

MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis

LA JOLLA, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it was notified by Sanofi that the Sanofi/Novartis litigation was settled. Accordingly, MediciNova is entitled to receive a certain amount of monetary damages through this settlement. Further details will be provided as they become available.

The rest is here:
MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis

Santhera Enters into Exclusive Supply Agreement for AGAMREE® (Vamorolone) with Ali Al Suwaidi Trading Establishment (ASTE) in Qatar

Pratteln, Switzerland, November 12, 2024 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive supply agreement with Ali Al Suwaidi Trading Est. (ASTE) for the treatment of patients with Duchenne muscular dystrophy (DMD) with AGAMREE under a Named Patient Program.

Link:
Santhera Enters into Exclusive Supply Agreement for AGAMREE® (Vamorolone) with Ali Al Suwaidi Trading Establishment (ASTE) in Qatar

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Saint-Herblain (France), November 12, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe.

Link:
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

SAN DIEGO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced its financial results for the third quarter ended September 30, 2024, and provided a general business update.

See the original post here:
Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms

PARIS and CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, provided an update on operational progress and reported financial results for the third quarter of 2024.

Continued here:
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms

Strengthening Community Bonds Through Health Efforts

A genuine passion for health and well-being can spark transformative change within communities, empowering individuals to shape healthier lifestyles and influence public health. Through dedication to advocacy, people find ways to impact their surroundings and promote widespread improvements in wellness. Opportunities for involvement span across careers, community projects, and policy efforts, creating diverse pathways to make a difference. Every action, from supporting health-focused initiatives to collaborating on sustainable practices, strengthens a larger movement toward societal wellness. 

Crafting a Health-Focused Career Path

Embarking on a career that supports health initiatives can be incredibly rewarding. Before you dive into the job market, it’s essential to present yourself professionally. Utilizing a resume maker can help you create a standout resume. With a variety of customizable templates, you can tailor your resume to reflect your unique skills and experiences, ensuring you make a strong impression in the competitive healthcare field.

Empowering Communities Through Chronic Illness Support Groups

Creating support groups for those with chronic illnesses can significantly enhance community well-being. These groups provide a platform for sharing resources and mutual encouragement, often facilitated by mental health professionals. By participating in these groups, you can connect with others who understand your experiences, fostering a sense of belonging and reducing isolation. These groups are accessible to everyone, including BIPOC and LGBTQIA+ communities, as they are free and conducted virtually.

Empower Your Community Through Free Fitness Workshops

Offering free fitness workshops provides an effective way to share your passion for health with the community. Covering a broad range of wellness topics, these workshops reflect key standards in health education. Engaging with participants strengthens your reputation as a trusted expert while motivating people to make healthier choices. These interactions foster a supportive environment that encourages lasting interest in personal wellness.

Influence Local Mental Health Policies Through Active Participation

Attending local government meetings is a powerful way to advocate for mental health policies. By sharing your experiences and knowledge, you can keep mental health issues at the forefront of policymakers’ agendas. Engaging in dialogue with mayors, city council members, and county commissioners helps ensure that mental health remains a priority, allowing you to build relationships and position yourself as a valuable resource.

Empower Your Community by Partnering with Local Farmers

Collaborating with local farmers can enhance your community’s access to fresh produce. Establishing farmers’ markets in accessible locations ensures that fresh fruits and vegetables are available to everyone. This initiative supports local farmers and encourages larger retailers to invest in the community, bringing both economic and health benefits.

Harnessing Healthcare Expertise for Community Well-being

Creating a volunteer network of healthcare professionals can significantly enhance community health. With nonprofit hospitals operating on tight margins, volunteers provide essential services without financial compensation. By organizing a network of dedicated healthcare volunteers, you can help bridge the gap in healthcare access, ensuring underserved populations receive the care they need.

Enhancing Community Health Initiatives Through Expert Collaboration

Partnering with local health professionals can boost the effectiveness of your community health workshops. These experts bring valuable insights into the latest advancements in public health, enriching the content of your workshops. Collaborating with them ensures that the information shared is accurate and up-to-date, empowering you to make a substantial impact on community health.

 

Health advocacy is a journey of collective empowerment, where individual efforts contribute to a larger movement for societal well-being. By engaging in diverse initiatives, you not only foster healthier communities but also inspire others to join in the pursuit of public health excellence. Your commitment to health advocacy can create ripples of change, leading to a more vibrant and resilient society.

Discover the latest breakthroughs in stem cell research and innovative therapies by visiting the Stem Cell Clinic today!

Image by Freepik